Unicycive Therapeutics (UNCY) Share-based Compensation (2020 - 2026)
Unicycive Therapeutics (UNCY) reported Share-based Compensation of $2.88 million for Q2 2026, up 403.9% from $571,000 a year earlier and up 281.6% from the prior quarter.
Powered by 
Analysis
Unicycive Therapeutics (UNCY) Share-based Compensation (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Unicycive Therapeutics' Share-based Compensation came in at $5.14 million, up 121.4% year-over-year; for FY2025, it came in at $2.64 million, up 12.4% from FY2024.
- Share-based Compensation has increased for three consecutive years, with a five-year compound annual growth rate of 79.7% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $2.35 million in FY2024 (+33.0%), $1.77 million in FY2023 (+68.8%), $1.05 million in FY2022 (-52.2%) and $2.19 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Share-based Compensation in data going back to Q2 2020.
- Year over year, Share-based Compensation has now increased in each of the last four quarters, with growth averaging 57.5% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was Q2 2026 (growth of 403.9%); the low point was Q2 2022 (a decline of 51.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $754,000 (Q1 2026), $777,000 (Q4 2025) and $730,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.71 Bn | 1,140.30 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 642.13 Bn | 560.65 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 501.64 Bn | 474.75 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 375.66 Bn | 330.04 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 302.79 Bn | 266.78 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 268.68 Bn | 242.37 Bn | 12.86 Bn | - |
| 7 | Amgen | 242.43 Bn | 197.83 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 193.69 Bn | 167.89 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.47 Bn | 119.12 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Unicycive Therapeutics | 104.71 Mn | -95.27 Mn | - | 2.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.88 Mn |
| Mar 31, 2026 | 754,000.00 |
| Dec 31, 2025 | 777,000.00 |
| Sep 30, 2025 | 729,000.00 |
| Jun 30, 2025 | 571,000.00 |
| Mar 31, 2025 | 563,000.00 |
| Dec 31, 2024 | 582,000.00 |
| Sep 30, 2024 | 605,000.00 |
| Jun 30, 2024 | 641,000.00 |
| Mar 31, 2024 | 522,000.00 |
| Dec 31, 2023 | 550,000.00 |
| Sep 30, 2023 | 929,000.00 |
| Jun 30, 2023 | 144,000.00 |
| Mar 31, 2023 | 144,000.00 |
| Dec 31, 2022 | 197,000.00 |
| Sep 30, 2022 | 266,000.00 |
| Jun 30, 2022 | 294,000.00 |
| Mar 31, 2022 | 290,000.00 |
| Sep 30, 2021 | 239,000.00 |
| Jun 30, 2021 | 294,000.00 |
API Access
Unicycive Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=UNCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "UNCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=UNCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();